Barrett & Company’s BioVie BIVI Stock Holding History

Barrett & Company’s Portfolio BIVI Stock Details BIVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3	Closed	-$1.02K	–	618
2023 Q3	$1.02K	Hold	3	–	–	﹤0.01%	579
2023 Q2	$1.29K	Hold	3	–	–	﹤0.01%	556
2023 Q1	$2.42K	Hold	3	–	–	﹤0.01%	498
2022 Q4	$2.33K	Hold	3	–	–	﹤0.01%	506
2022 Q3	$2.33K	Buy	+3	New	+$714	﹤0.01%	506

Other funds holding BIVI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Barrett & Company's BIVI Position: Q4 2023 in Review

Barrett & Company sold out of BioVie (BIVI) in Q4 2023, closing a stake of 3 shares — an estimated $1.02K sold.

Barrett & Company first reported a position in BIVI in Q3 2022 and held it in 5 quarters. The position peaked at $2.42K in Q1 2023. 53 funds tracked by Wall St. Rank hold BIVI as of Q4 2023.

Barrett & Company reported no remaining BioVie position as of Q4 2023 after selling out during the quarter.
Barrett & Company sold 3 BioVie shares in Q4 2023, an estimated $1.02K.
Barrett & Company first reported a position in BioVie in Q3 2022 and held it in 5 quarters.
Barrett & Company's BioVie position peaked at $2.42K in Q1 2023.
53 funds tracked by Wall St. Rank held BioVie as of Q4 2023.

Based on Barrett & Company's 13F filing for Q4 2023, filed 24 Jan 2024.